ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...
UCLA-led researchers identified a molecular switch that prevents lung blood vessel repair in bronchopulmonary dysplasia.
At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of preeclampsia, according to a study in ...
Proliferative vitreoretinopathy (PVR) is an eye condition that leads to blindness and can currently only be addressed with surgery. A team led by research hospital Massachusetts Eye and Ear and German ...
Researchers developed cSMRTS, an engineered mRNA that preferentially turns on therapeutic genes inside targeted cells, shown in mice, enabling safer, more precise treatments. (Nanowerk News) ...
A freshman Idaho lawmaker wants to ban most COVID-19 shots for the next decade, with a bill rooted in misconceptions about vaccines that thrived during the pandemic. The bill from Sen. Brandon Shippy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback